Nutritional Status after Roux-En-Y (Rygb) and One Anastomosis Gastric Bypass (Oagb) at 6-Month Follow-Up: A Comparative Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
09 Jul 2022
Historique:
received: 20 06 2022
revised: 01 07 2022
accepted: 08 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Roux-en-Y gastric bypass (RYGB) and one anastomosis gastric bypass (OAGB) are two effective bariatric surgical procedures with positive outcomes in terms of weight loss, comorbidities remission, and adverse events profiles. OAGB seems to carry a higher risk of malnutrition, but existing data are controversial. The aim of this study is to objectively evaluate and compare malnutrition in patients undergoing RYGB and OAGB. Retrospective monocentric study of obese patients undergoing RYGB or OAGB between the 15 September 2020 and the 31 May 2021. Nutritional status was assessed using the Controlling Nutritional Status (CONUT) score and compared between groups. The primary outcome was the mean CONUT score at 6 months. The secondary outcomes included the incidence of malnutrition, comorbidities, including hypertension, insulin resistance and type II diabetes mellitus, and weight loss. 78 patients were included: 30 underwent RYGB and 48 underwent OAGB. At 6-Month Follow-Up there was no difference between groups in the mean CONUT score nor in incidence of malnutrition. In both groups, the nutritional status significantly worsened 6 months after surgery (preoperative and postoperative score of 0.48 ± 0.9 and 1.38 ± 1.5; No difference in nutritional status has been detected between patients undergoing RYGB or OAGB at the 6-Month Follow-Up. Both procedures may have significant mal-absorptive effects leading to decline in nutritional status. OAGB may be more efficacious in inducing DMII and hypertension remission. Larger prospective studies dedicated specifically to nutritional status after gastric bypass are needed to confirm the impact of different bypass procedures on nutritional status.

Identifiants

pubmed: 35889780
pii: nu14142823
doi: 10.3390/nu14142823
pmc: PMC9324253
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Colorectal Dis. 2018 Aug;20(8):O215-O225
pubmed: 29897171
Br J Surg. 2021 Aug 19;108(8):892-897
pubmed: 34297806
Nutrients. 2021 Oct 12;13(10):
pubmed: 34684569
BMC Surg. 2020 Oct 12;20(1):232
pubmed: 33046020
Obes Surg. 2021 Aug;31(8):3557-3564
pubmed: 33880746
Surg Endosc. 2022 Jan;36(1):328-335
pubmed: 33479836
Obes Surg. 1996 Apr;6(2):145-150
pubmed: 10729855
Obes Surg. 2020 Oct;30(10):3685-3694
pubmed: 32458362
Surg Obes Relat Dis. 2008 Jul-Aug;4(4):521-5; discussion 526-7
pubmed: 18539540
Obes Surg. 2021 Aug;31(8):3715-3726
pubmed: 34031850
Semin Laparosc Surg. 2001 Jun;8(2):114-25
pubmed: 11441400
Obes Surg. 2016 Mar;26(3):660-71
pubmed: 26749410
Obes Surg. 2021 Oct;31(10):4528-4541
pubmed: 34363144
Obes Surg. 2021 Jun;31(6):2619-2631
pubmed: 33624210
Obes Surg. 2011 Dec;21(12):1849-58
pubmed: 21984052
Obes Surg. 2001 Jun;11(3):276-80
pubmed: 11433900
Obes Surg. 2019 Sep;29(9):2721-2730
pubmed: 31172454
Nat Rev Gastroenterol Hepatol. 2017 Mar;14(3):160-169
pubmed: 27899816
Surg Endosc. 2004 Feb;18(2):232-6
pubmed: 14691705
J Clin Endocrinol Metab. 2012 Dec;97(12):4724-32
pubmed: 23027922
Surg Obes Relat Dis. 2020 Apr;16(4):476-484
pubmed: 32035829
Cureus. 2022 Jan 11;14(1):e21114
pubmed: 35036236
Biochem J. 2018 Mar 15;475(5):1019-1035
pubmed: 29437994
Obes Surg. 2020 Sep;30(9):3528-3535
pubmed: 32405910
Updates Surg. 2017 Mar;69(1):101-107
pubmed: 28266000
J Nutr Sci. 2020 Oct 08;9:e46
pubmed: 33101663
Eat Weight Disord. 2021 Oct;26(7):2211-2218
pubmed: 33226607
Obes Surg. 2020 Nov;30(11):4206-4217
pubmed: 32562132
World J Surg. 2020 Mar;44(3):855-862
pubmed: 31641833
J Obes. 2022 Jan 29;2022:4942052
pubmed: 35132363
Obes Surg. 2021 Apr;31(4):1411-1421
pubmed: 33517557
J Laparoendosc Adv Surg Tech A. 2020 Dec;30(12):1320-1328
pubmed: 32543277
Obes Surg. 2020 Apr;30(4):1211-1218
pubmed: 31749109
Trials. 2021 May 19;22(1):352
pubmed: 34011386
Lancet. 2019 Mar 30;393(10178):1299-1309
pubmed: 30851879
Nutrients. 2022 Jan 12;14(2):
pubmed: 35057486
Int J Obes (Lond). 2005 Feb;29(2):196-203
pubmed: 15570311
Endocr Pract. 2019 Dec;25(12):1346-1359
pubmed: 31682518

Auteurs

Paolo Gentileschi (P)

Department of Surgery, University of Rome Tor Vergata, 00133 Rome, Italy.
Department of Bariatric and Metabolic Surgery, San Carlo di Nancy Hospital, 00165 Rome, Italy.

Leandro Siragusa (L)

Department of Surgery, University of Rome Tor Vergata, 00133 Rome, Italy.
Department of Bariatric and Metabolic Surgery, San Carlo di Nancy Hospital, 00165 Rome, Italy.

Federica Alicata (F)

Department of Surgery, University of Rome Tor Vergata, 00133 Rome, Italy.
Department of Bariatric and Metabolic Surgery, San Carlo di Nancy Hospital, 00165 Rome, Italy.

Michela Campanelli (M)

Department of Surgery, University of Rome Tor Vergata, 00133 Rome, Italy.
Department of Bariatric and Metabolic Surgery, San Carlo di Nancy Hospital, 00165 Rome, Italy.

Chiara Bellantone (C)

Department of Nutritional Sciences, San Carlo di Nancy Hospital, 00165 Rome, Italy.

Tania Musca (T)

Department of Nutritional Sciences, San Carlo di Nancy Hospital, 00165 Rome, Italy.

Emanuela Bianciardi (E)

Psychiatry Unit, Department of Medical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.

Claudio Arcudi (C)

Department of Surgery, University of Rome Tor Vergata, 00133 Rome, Italy.
Department of Bariatric and Metabolic Surgery, San Carlo di Nancy Hospital, 00165 Rome, Italy.

Domenico Benavoli (D)

Department of Surgery, University of Rome Tor Vergata, 00133 Rome, Italy.
Department of Bariatric and Metabolic Surgery, San Carlo di Nancy Hospital, 00165 Rome, Italy.

Bruno Sensi (B)

Department of Surgery, University of Rome Tor Vergata, 00133 Rome, Italy.
Department of Bariatric and Metabolic Surgery, San Carlo di Nancy Hospital, 00165 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH